News Headlines Article

Proposed changes to 340B could drive away a third of participating hospitals
Modern Healthcare

Up to a third of hospitals currently participating in the 340B drug-pricing program say they would consider opting out if proposed regulatory changes are finalized, a leading advocacy group said on Wednesday.

More than a quarter of the 2,100 hospitals that participate in the drug-discount program would be significantly affected by the provisions included within the Health Resources and Services Administration’s draft omnibus guidance released in August, according to the advocacy group 340B Health. CEO Ted Slafsky said a survey of its 1,100 members found 29% of them would drop out of the 340B program if the draft guidance was finalized as it currently is written.